Exor NV
DUS:EYX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
E
|
Exor NV
DUS:EYX
|
NL |
|
S
|
Sigma Healthcare Ltd
F:S5YA
|
AU |
|
R
|
Relx PLC
DUS:RDEB
|
UK |
|
R
|
RH
XMUN:RS1
|
US |
|
Aspen Pharmacare Holdings Ltd
F:LDZU
|
ZA |
|
C
|
Caseys General Stores Inc
SWB:CS2
|
US |
|
Bioporto A/S
F:2P4
|
DK |
|
B
|
Barrick Gold Corp
DUS:ABR
|
CA |
|
R
|
Royal Unibrew A/S
F:0R1
|
DK |
|
S
|
Stroeer SE & Co KgaA
XMUN:SAX
|
DE |
|
A
|
Aperam SA
XMUN:7AA
|
LU |
Wall St Price Targets
EYX Price Targets Summary
Exor NV
According to Wall Street analysts, the average 1-year price target for
EYX is 112.91 EUR with a low forecast of 104.41 EUR and a high forecast of 126.46 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is EYX's stock price target?
Price Target
112.91
EUR
According to Wall Street analysts, the average 1-year price target for
EYX is 112.91 EUR with a low forecast of 104.41 EUR and a high forecast of 126.46 EUR.